glp-1 weight loss risks Long-Term Effects Of Medications: What You Should Know GLP-1 Medications for Weight Loss:

Quick Stats for Obesity GLP-1 Market Obesity GLP-1 Market Value (2025): USD 8,169 million Obesity GLP-1 Market Forecast Value (2035): USD 65,364 million Obesity GLP-1 Market Forecast CAGR: 23.1% Leading Molecule Class in Obesity GLP-1 Market: Semaglutide (58.0%) Key Growth Regions in Obesity GLP-1 Market: North America, Europe, and East Asia Top Key Players in Obesity GLP-1 Market: Novo Nordisk, Eli Lilly, and emerging manufacturers Between 2025 and 2030, the obesity GLP-1 market is projected to expand from USD 8169.0 million to USD 39,528 million, resulting in a value increase of USD 31359.0 million, which represents 54.8% of the total forecast growth for the decade

It also slows the rate at which the stomach empties, promoting a feeling of fullness, and tells the brain to reduce hunger

The gut-thyroid axis and why it matters Research has revealed a bidirectional relationship between intestinal health and thyroid function that researchers call the gut-thyroid axis

A significance level of alpha = 0.05 was adopted for all analyses